PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 12.256
AS - Asia 6.201
EU - Europa 3.303
SA - Sud America 1.078
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 188
OC - Oceania 13
Totale 23.459
Nazione #
US - Stati Uniti d'America 11.868
SG - Singapore 2.356
CN - Cina 1.475
IE - Irlanda 1.106
HK - Hong Kong 980
BR - Brasile 793
VN - Vietnam 558
IT - Italia 536
RU - Federazione Russa 513
FR - Francia 345
DE - Germania 201
IN - India 176
GB - Regno Unito 172
CA - Canada 165
BD - Bangladesh 117
FI - Finlandia 106
AR - Argentina 86
IQ - Iraq 80
MX - Messico 69
JP - Giappone 66
ZA - Sudafrica 63
CO - Colombia 57
EC - Ecuador 51
NL - Olanda 51
PK - Pakistan 45
TR - Turchia 41
BE - Belgio 38
PL - Polonia 36
SE - Svezia 36
UZ - Uzbekistan 36
ID - Indonesia 34
VE - Venezuela 34
AT - Austria 33
ES - Italia 32
CR - Costa Rica 26
PH - Filippine 25
SA - Arabia Saudita 25
JM - Giamaica 24
MA - Marocco 24
MY - Malesia 23
KE - Kenya 20
JO - Giordania 19
KR - Corea 19
AZ - Azerbaigian 18
HN - Honduras 18
MU - Mauritius 17
CL - Cile 16
IL - Israele 14
TT - Trinidad e Tobago 14
EG - Egitto 13
NI - Nicaragua 13
OM - Oman 13
PR - Porto Rico 13
PY - Paraguay 13
TN - Tunisia 13
UA - Ucraina 13
UY - Uruguay 12
PE - Perù 11
KG - Kirghizistan 10
LT - Lituania 10
SV - El Salvador 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
EE - Estonia 9
AL - Albania 8
DZ - Algeria 8
GT - Guatemala 8
NP - Nepal 8
PT - Portogallo 8
RO - Romania 8
TH - Thailandia 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
IR - Iran 6
AM - Armenia 5
BO - Bolivia 5
GP - Guadalupe 5
GR - Grecia 5
KW - Kuwait 5
KZ - Kazakistan 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
LB - Libano 4
LV - Lettonia 4
PA - Panama 4
AO - Angola 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
LY - Libia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BS - Bahamas 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
Totale 22.998
Città #
Chandler 1.531
San Jose 1.480
Singapore 1.365
Ashburn 1.237
Dublin 1.102
Hong Kong 964
Council Bluffs 663
Dallas 641
Beijing 349
Boardman 333
Princeton 303
Lauterbourg 295
Lawrence 288
Wilmington 286
Los Angeles 237
Ho Chi Minh City 202
Medford 180
Santa Clara 169
Hanoi 137
Redondo Beach 135
Buffalo 114
The Dalles 106
Fairfield 101
New York 96
Ann Arbor 90
Shanghai 89
Columbus 85
Chicago 79
Helsinki 79
Rome 71
Falls Church 66
Moscow 66
Seattle 65
Milan 64
Tokyo 61
Washington 61
Norwalk 58
São Paulo 56
Phoenix 49
Brooklyn 48
Woodbridge 48
Frankfurt am Main 47
Johannesburg 47
Munich 47
Atlanta 43
Orem 42
North Bergen 41
Brussels 38
San Francisco 38
Da Nang 36
Guangzhou 35
Tashkent 32
Montreal 30
Houston 29
Chennai 28
Mexico City 28
Toronto 28
Rio de Janeiro 27
Brasília 25
Nanjing 25
Denver 24
Haiphong 24
Pune 24
Warsaw 24
Baghdad 23
Nuremberg 23
Turku 23
Amsterdam 22
Belo Horizonte 22
Boston 22
London 22
Changsha 20
Stockholm 20
Quito 19
Falkenstein 18
Nairobi 18
Pavia 18
Philadelphia 18
San José 18
Medellín 17
Newark 17
Tianjin 17
Amman 16
Naples 16
Seoul 16
Shijiazhuang 16
Baku 15
Bologna 15
Jakarta 15
Charlotte 14
City of London 14
Hangzhou 14
Palermo 14
Dhaka 13
Managua 13
Poplar 13
Porto Alegre 13
Queens 13
Turin 13
Bogotá 12
Totale 14.823
Nome #
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 169
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 132
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 125
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 122
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission 117
Oxytocin Modifies the Excitability and the Action Potential Shape of the Hippocampal CA1 GABAergic Interneurons 116
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 115
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 114
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 112
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 112
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 111
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 109
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 108
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 108
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 107
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 105
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 105
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons 104
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 103
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 103
Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients 103
Acetylcholine-mediated modulation of striatal function 102
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 101
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 101
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 100
Corticostriatal synaptic plasticity in PINK1 heterozygous mice: Effects of mitochondrial complex I inhibition 97
Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia 97
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons 97
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 96
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 96
A2a receptor dysregulation in dystonia dyt1 knock-out mice 96
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 96
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum 93
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 92
The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum 90
Facemasks and face recognition: Potential impact on synaptic plasticity 90
Expanding the phenotype of Brunner syndrome from childhood to adulthood: Description of the second pediatric patient and his mother 89
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 88
The neuroligins and the synaptic pathway in Autism Spectrum Disorder 88
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice 88
Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition 88
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 88
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia 88
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 88
Diagnostic and Prognostic Value of External Anal Sphincter EMG Patterns in Multiple System Atrophy 88
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine 87
Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data 87
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology 87
Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway 86
Dystonia 86
Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis 86
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 86
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 85
Hypoxia-induced electrical changes in striatal neurons 85
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 85
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 85
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 84
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum 84
Dystonia as a network disorder: A concept in evolution 83
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 83
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 83
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 83
Facemasks and face recognition: Potential impact on synaptic plasticity 83
Artificial Intelligence-Based Voice Assessment of Patients with Parkinson's Disease Off and On Treatment: Machine vs. Deep-Learning Comparison 82
Electrophysiological evidence of subclinical trigeminal dysfunction in patients with COVID-19 and smell impairment: A pilot study 82
Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures 82
Promising rodent models in Parkinson's disease 82
Does SARS-Cov-2 invade the brain? Translational lessons from animal models 82
Axial postural abnormalities and pain in Parkinson's disease 81
Synaptic Dysfunction in Dystonia: Update From Experimental Models 81
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 81
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 81
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 81
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia 81
Neuromodulatory functions exerted by oxytocin on different populations of hippocampal neurons in rodents 80
Synaptic transmission in the striatum: from plasticity to neurodegeneration 80
Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review 80
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection 79
Dopaminergic involvement in a drummer with focal dystonia: A case study 79
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 79
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 79
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 79
Voice Disorder Multi-Class Classification for the Distinction of Parkinson's Disease and Adductor Spasmodic Dysphonia 78
Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway 78
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 78
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19 77
Metabotropic glutamate receptors and neuronal toxicity 77
Models of dystonia: an update 77
Muscarinic IPSPs in rat striatal cholinergic interneurones 77
Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia 76
Hypoxia in striatal and cortical neurones: membrane potential and Ca2+ measurements 76
Engineering animal models of dystonia 76
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 76
Post-receptor mechanisms underlying striatal long-term depression 76
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 76
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 76
L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons 76
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 75
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies 75
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism 75
Totale 9.071
Categoria #
all - tutte 127.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.106 0 0 0 0 32 47 42 100 91 18 162 614
2022/20233.617 367 170 63 396 289 461 4 264 1.417 27 93 66
2023/20241.440 151 227 84 101 158 445 66 70 10 63 34 31
2024/20254.121 101 360 100 172 147 247 230 194 1.007 211 512 840
2025/20269.156 531 578 1.045 726 1.046 374 2.256 389 738 697 423 353
2026/20273.278 397 687 886 1.200 108 0 0 0 0 0 0 0
Totale 23.459